Related Experiment Video
Updated: Mar 6, 2026
06:47
Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
9.9K
Berberine bioisostere Q8 compound stimulates osteoblast differentiation and function in vitro
Younho Han1, Yifeng Jin1, Sung Ho Lee1
1College of Pharmacy & Research Institute of Drug Development, Chonnam National University, Gwangju 500-757, Republic of Korea.
Pharmacological Research
|March 14, 2017
Summary
The novel compound Q8, a berberine derivative, promotes bone regeneration by enhancing osteoblast differentiation. It stabilizes key proteins, Runx2 and Osterix, via protein kinase A signaling, offering potential for osteoporosis prevention.
Area of Science:
- Biochemistry
- Molecular Biology
- Orthopedics
Background:
- Berberine derivatives are explored for therapeutic potential.
- Osteoblast differentiation is crucial for bone regeneration and osteoporosis prevention.
- Understanding molecular mechanisms regulating osteogenesis is vital.
Purpose of the Study:
- To investigate the functional role of the unique berberine derivative, Q8, in osteoblast differentiation.
- To elucidate the molecular pathways underlying Q8's effects on bone regeneration.
- To evaluate Q8's potential for preventing osteoporosis.
Main Methods:
- Assessing alkaline phosphatase (ALP) activity and gene/protein expression (ALP, BSP, OC) in osteoblasts.
- Utilizing luciferase reporter assays to measure transcriptional activity.
- Investigating the role of the ubiquitin-proteasome pathway and key transcription factors (Runx2, Osterix).
- Examining signal transduction pathways using kinase inhibitors, specifically targeting protein kinase A (PKA).
Main Results:
- Q8 increased BMP4-induced ALP activity and the expression of osteogenic markers (ALP, BSP, OC).
- Q8 stabilized Runx2 and Osterix protein levels by inhibiting the ubiquitin-proteasome pathway, enhancing their transcriptional activity.
- Depletion of Runx2/Osterix abolished Q8's bone anabolic effects.
- Inhibition of PKA signaling with H89 blocked Q8-mediated Runx2/Osterix regulation.
Conclusions:
- Q8 promotes osteoblast differentiation and bone regeneration.
- The mechanism involves Q8 stabilizing Runx2/Osterix via PKA signaling activation.
- Q8 demonstrates potential as a therapeutic agent for osteoporosis prevention.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
4.5K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.5K
01:31Essential Minerals for Bone Health
6.9K
The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
6.9K